Metapneumonia Virus A RNA Detection Qualitative Test
At DNA Labs UAE, we offer the Metapneumonia Virus A RNA Detection Qualitative Test for the diagnosis of Metapneumonia Virus A infections. This test is designed to detect the presence of Metapneumonia Virus A RNA in a patient’s sample.
Test Details
The Metapneumonia Virus A RNA Detection Qualitative Test is a diagnostic test used to detect the presence of Metapneumonia Virus A RNA in a patient’s sample. Metapneumonia Virus A is a respiratory virus that can cause severe respiratory illness in humans.
The test utilizes a molecular technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect the viral RNA. The process involves converting the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase. The cDNA is then amplified using PCR, which creates millions of copies of the viral genetic material.
The test requires a sample from the patient, such as a nasopharyngeal swab or respiratory secretions. The sample is processed in a laboratory, where the viral RNA is extracted and purified. The extracted RNA is then subjected to the RT-PCR process, which detects and amplifies the viral genetic material.
Test Name
Metapneumonia Virus A RNA Detection Qualitative Test
Components
- Price: 1200.0 AED
- Sample Condition: Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC.
Report Delivery
4th Working Day Email: 48 hours
On phone: 36 hours
Method
Real Time PCR
Test Type
Viral
Doctor
Physician
Test Department
Genetics
Pre Test Information
Patients need to sign a Consent document and bring any clinical history of the patient for the Metapneumonia Virus A (RNA Detection) Qualitative Test.
Benefits of the Test
The Metapneumonia Virus A RNA Detection Qualitative Test is a highly sensitive and specific method for diagnosing Metapneumonia Virus A infections. It can help healthcare providers make accurate and timely diagnoses, enabling appropriate treatment and infection control measures to be implemented.
| Test Name | Metapneumonia Virus A RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 1200.0 AED |
| Sample Condition | Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC. |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forMetapneumonia Virus A (RNA Detection) QualitativeTest |
| Test Details |
The Metapneumonia Virus A (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of Metapneumonia Virus A RNA in a patient’s sample. Metapneumonia Virus A is a respiratory virus that can cause severe respiratory illness in humans. The test utilizes a molecular technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect the viral RNA. The process involves converting the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase. The cDNA is then amplified using PCR, which creates millions of copies of the viral genetic material. The test requires a sample from the patient, such as a nasopharyngeal swab or respiratory secretions. The sample is processed in a laboratory, where the viral RNA is extracted and purified. The extracted RNA is then subjected to the RT-PCR process, which detects and amplifies the viral genetic material. If the test result is positive, it indicates that the patient is currently infected with Metapneumonia Virus A. A negative result, on the other hand, suggests the absence of viral RNA in the sample, indicating that the patient is not currently infected. The Metapneumonia Virus A (RNA Detection) Qualitative Test is a highly sensitive and specific method for diagnosing Metapneumonia Virus A infections. It can help healthcare providers make accurate and timely diagnoses, enabling appropriate treatment and infection control measures to be implemented. |
